Skip to main content
SpringerLink
Log in

The Many Faces of Arterial Hypertension in Hypertrophic Cardiomyopathy and Its Phenocopies: Bystander, Consequence, Modifier

  • Commentary
  • Published:
High Blood Pressure & Cardiovascular Prevention Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Volpe M, Gallo G, Battistoni A, Tocci G. Implications of guidelines for hypertension management in Europe. Circ Res. 2019;124:972–4.

    Article  CAS  Google Scholar 

  2. Nadruz W. Myocardial remodeling in hypertension. J Hum Hypertens. 2015;29:1–6.

    Article  CAS  Google Scholar 

  3. Rosei EA, de Simone G, Mureddu G, Trimarco B, Verdecchia P, Volpe M. Arterial hypertension and cardiac damage. High Blood Press Cardiovasc Prev. 2008;15:141–70.

    Article  Google Scholar 

  4. Elliott PM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F, Charron P, et al. 2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J. 2014;35:2733–79.

    Article  Google Scholar 

  5. Elliott P, Baker R, Pasquale F, Quarta G, Ebrahim H, Mehta AB, et al. Prevalence of Anderson-Fabry disease in patients with hypertrophic cardiomyopathy: the European Anderson-Fabry Disease Survey. Heart. 2011;97:1957–60.

    Article  Google Scholar 

  6. Canepa M, Tini G, Musumeci B, Cappelli F, Milandri A, Mussinelli R, et al. Real-world versus trial patients with transthyretin amyloid cardiomyopathy. Eur J Heart Fail. 2019;21:1479–81.

    Article  Google Scholar 

  7. Canepa M, Fumagalli C, Tini G, Vincent-Tompkins J, Day SM, Ashley EA, et al. Temporal trend of age at diagnosis in hypertrophic cardiomyopathy: an analysis of the international sarcomeric human cardiomyopathy registry. Circ Heart Fail. 2020;13:e007230.

    Article  CAS  Google Scholar 

  8. Olivotto I, Marchionni N. No heart is an island: hypertrophic cardiomyopathy, diabetes, and the test of time. Eur Heart J. 2019;40:1678–80.

    Article  Google Scholar 

  9. Rossi F, Svarstad E, Elsaid H, Binaggia A, Roggero L, Auricchio S, et al. Elevated ambulatory blood pressure measurements are associated with a progressive form of Fabry disease. High Blood Press Cardiovasc Prev. 2021. https://doi.org/10.1007/s40292-021-00450-0.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Del Pinto R, Ferri C. The role of immunity in Fabry disease and hypertension: a review of a novel common pathway. High Blood Press Cardiovasc Prev. 2020;27:539–46.

    Article  Google Scholar 

  11. Chimenti C, Scopelliti F, Vulpis E, Tafani M, Villanova L, Verardo R, et al. Increased oxidative stress contributes to cardiomyocyte dysfunction and death in patients with Fabry disease cardiomyopathy. Hum Pathol. 2015;46:1760–8.

    Article  CAS  Google Scholar 

  12. Repetti GG, Kim Y, Pereira AC, Ingles J, Russell MW, Lakdawala NK, et al. Discordant clinical features of identical hypertrophic cardiomyopathy twins. Proc Natl Acad Sci USA. 2021;118(10):e2021717118. https://doi.org/10.1073/pnas.2021717118.

    Article  CAS  PubMed  Google Scholar 

  13. Duro G, Musumeci MB, Colomba P, Zizzo C, Albeggiani G, Mastromarino V, et al. Novel α-galactosidase A mutation in patients with severe cardiac manifestations of Fabry disease. Gene. 2014;535:365–9.

    Article  CAS  Google Scholar 

  14. Musumeci MB, Russo D, Limite LR, Canepa M, Tini G, Casenghi M, et al. Long-term left ventricular remodeling of patients with hypertrophic cardiomyopathy. Am J Cardiol. 2018;122:1924–31.

    Article  Google Scholar 

  15. Tini G, Vianello PF, Gemelli C, Grandis M, Canepa M. Amyloid cardiomyopathy in the rare transthyretin Tyr78Phe mutation. J Cardiovasc Transl Res. 2019;12:514–6.

    Article  Google Scholar 

  16. Maron BJ, Maron MS, Maron BA, Loscalzo J. Moving beyond the sarcomere to explain heterogeneity in hypertrophic cardiomyopathy. J Am Coll Cardiol. 2019;73:1978–86.

    Article  Google Scholar 

  17. Walsh R, Tadros R, Bezzina CR. When genetic burden reaches threshold. Eur Heart J. 2020;41:3849–55.

    Article  CAS  Google Scholar 

  18. Cerrone M, Remme CA, Tadros R, Bezzina CR, Delmar M. Beyond the one gene-one disease paradigm: complex genetics and pleiotropy in inheritable cardiac disorders. Circulation. 2019;140:595–610.

    Article  Google Scholar 

  19. Toepfer CN, Garfinkel AC, Venturini G, Wakimoto H, Repetti G, Alamo L, et al. Myosin sequestration regulates sarcomere function, cardiomyocyte energetics, and metabolism, informing the pathogenesis of hypertrophic cardiomyopathy. Circulation. 2020;141:828–42.

    Article  CAS  Google Scholar 

  20. Aistrup GL, Gupta DK, Kelly JE, O’Toole MJ, Nahhas A, Chirayil N, et al. Inhibition of the late sodium current slows t-tubule disruption during the progression of hypertensive heart disease in the rat. Am J Physiol Heart Circ Physiol. 2013;305:H1068-1079.

    Article  CAS  Google Scholar 

  21. Coppini R, Ferrantini C, Yao L, Fan P, Del Lungo M, Stillitano F, et al. Late sodium current inhibition reverses electromechanical dysfunction in human hypertrophic cardiomyopathy. Circulation. 2013;127:575–84.

    Article  CAS  Google Scholar 

  22. Harper AR, Goel A, Grace C, Thomson KL, Petersen SE, Xu X, et al. Common genetic variants and modifiable risk factors underpin hypertrophic cardiomyopathy susceptibility and expressivity. Nat Genet. 2021;53:135–42.

    Article  CAS  Google Scholar 

  23. Lever HM, Karam RF, Currie PJ, Healy BP. Hypertrophic cardiomyopathy in the elderly. Distinctions from the young based on cardiac shape. Circulation. 1989;79:580–9.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Cardiology, Sapienza University of Rome, Sant’Andrea Hospital, Via di Grottarossa, 1035-1039, 00189, Rome, Italy

    Giacomo Tini, Camillo Autore & Beatrice Musumeci

Authors
  1. Giacomo Tini
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Camillo Autore
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Beatrice Musumeci
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Giacomo Tini.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tini, G., Autore, C. & Musumeci, B. The Many Faces of Arterial Hypertension in Hypertrophic Cardiomyopathy and Its Phenocopies: Bystander, Consequence, Modifier. High Blood Press Cardiovasc Prev 28, 327–329 (2021). https://doi.org/10.1007/s40292-021-00458-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40292-021-00458-6

Search

Navigation